WuXi Biologics (Cayman) Inc. (FRA:1FW2)

Germany flag Germany · Delayed Price · Currency is EUR
3.653
+0.234 (6.86%)
At close: Dec 4, 2025
73.85%
Market Cap 14.80B
Revenue (ttm) 2.38B
Net Income (ttm) 498.77M
Shares Out n/a
EPS (ttm) 0.12
PE Ratio 29.67
Forward PE 23.07
Dividend n/a
Ex-Dividend Date n/a
Volume 6,000
Average Volume 1,677
Open 3.585
Previous Close 3.418
Day's Range 3.585 - 3.653
52-Week Range 1.982 - 4.682
Beta n/a
RSI 50.20
Earnings Date Nov 19, 2025

About WuXi Biologics

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufact... [Read more]

Industry Commercial Physical and Biological Research
Founded 2014
Employees 12,575
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 1FW2
Full Company Profile

Financial Performance

In 2024, WuXi Biologics's revenue was 18.68 billion, an increase of 9.63% compared to the previous year's 17.03 billion. Earnings were 3.36 billion, a decrease of -1.28%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.